Exploring TReg therapy to reduce post-transplant rejection
This summer, Santorini Scientific will be co-funding an internship with Imperial College London on Regulatory T-cell (TReg) therapy.
As the name suggests, TRegs are responsible for regulating immune responses therefore can be used to reduce autoimmune responses such as in cancer or, theoretically, rejection following a heart transplant.